» Articles » PMID: 31246956

The European Medicines Agency's Scientific Opinion on Oral Fexinidazole for Human African Trypanosomiasis

Overview
Date 2019 Jun 28
PMID 31246956
Citations 18
Authors
Affiliations
Soon will be listed here.
Citing Articles

Transforming the chemotherapy of human African trypanosomiasis.

Barrett M Clin Microbiol Rev. 2025; 38(1):e0015323.

PMID: 39772631 PMC: 11905362. DOI: 10.1128/cmr.00153-23.


Discovery of an orally active nitrothiophene-based antitrypanosomal agent.

Ajayi O, Metibemu D, Crown O, Adeyinka O, Kaiser M, Shoji N Eur J Med Chem. 2023; 263:115954.

PMID: 37984297 PMC: 10843616. DOI: 10.1016/j.ejmech.2023.115954.


Hypothesis-generating proteome perturbation to identify NEU-4438 and acoziborole modes of action in the African Trypanosome.

Sharma A, Cipriano M, Ferrins L, Hajduk S, Mensa-Wilmot K iScience. 2022; 25(11):105302.

PMID: 36304107 PMC: 9593816. DOI: 10.1016/j.isci.2022.105302.


Semi-Synthetic Analogues of Cryptolepine as a Potential Source of Sustainable Drugs for the Treatment of Malaria, Human African Trypanosomiasis, and Cancer.

Abacha Y, Forkuo A, Gbedema S, Mittal N, Ottilie S, Rocamora F Front Pharmacol. 2022; 13:875647.

PMID: 35600849 PMC: 9119314. DOI: 10.3389/fphar.2022.875647.


Chemotherapy for second-stage human African trypanosomiasis: drugs in use.

Lutje V, Probyn K, Seixas J, Bergman H, Villanueva G Cochrane Database Syst Rev. 2021; 12:CD015374.

PMID: 34882307 PMC: 8656462. DOI: 10.1002/14651858.CD015374.


References
1.
Priotto G, Pinoges L, Fursa I, Burke B, Nicolay N, Grillet G . Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study. BMJ. 2008; 336(7646):705-8. PMC: 2276259. DOI: 10.1136/bmj.39485.592674.BE. View

2.
Chappuis F . Oral fexinidazole for human African trypanosomiasis. Lancet. 2018; 391(10116):100-102. DOI: 10.1016/S0140-6736(18)30019-9. View

3.
Doua J, Van Geertruyden J . Registering medicines for low-income countries: how suitable are the stringent review procedures of the World Health Organisation, the US Food and Drug Administration and the European Medicines Agency?. Trop Med Int Health. 2013; 19(1):23-36. DOI: 10.1111/tmi.12201. View

4.
Buscher P, Cecchi G, Jamonneau V, Priotto G . Human African trypanosomiasis. Lancet. 2017; 390(10110):2397-2409. DOI: 10.1016/S0140-6736(17)31510-6. View

5.
Pelfrene E, Pinheiro M, Cavaleri M . Artemisinin-based combination therapy in the treatment of uncomplicated malaria: review of recent regulatory experience at the European Medicines Agency. Int Health. 2015; 7(4):239-46. PMC: 4492341. DOI: 10.1093/inthealth/ihv017. View